Company Profile

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE8038.65-59.2 (-0.73 % )
PREV CLOSE (Rs.) 8097.85
OPEN PRICE (Rs.) 8090.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1100
TODAY'S LOW / HIGH (Rs.)7995.00 8177.95
52 WK LOW / HIGH (Rs.)7322.1 8999
NSE8034.00 -60.2 (-0.74 % )
PREV CLOSE(Rs.) 8094.20
OPEN PRICE (Rs.) 8100.00
BID PRICE (QTY) 8034.00 (10 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 31163
TODAY'S LOW / HIGH(Rs.) 7990.00 8176.95
52 WK LOW / HIGH (Rs.)7306 8989

Board Meetings

Source Date Board Meeting Date Details
08-Feb-2021 23-Feb-2021 Final Dividend & Audited Results
13-Oct-2020 27-Oct-2020 Quarterly Results
15-Jul-2020 28-Jul-2020 Quarterly Results
12-May-2020 19-May-2020 Quarterly Results
25-Feb-2020 25-Feb-2020 Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2020, inter alia, has considered and approved the following : 1. Recommendation for payment of final dividend of Rs. 106 per equity share Rs. 10 each and one-time special dividend of Rs. 243 per equity share Rs. 10 each for the year ended December 31, 2019. The total dividend recommended is Rs. 349 per equity share Rs. 10 each for the year ended December 31, 2019. 2. The final as well as one-time special dividend, if approved by the shareholders will be paid on or after May 05, 2020.
05-Feb-2020 25-Feb-2020 Final Dividend & Audited Results
31-Oct-2019 12-Nov-2019 Quarterly Results
15-Jul-2019 29-Jul-2019 Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Monday, 29th July 2019; inter alia to consider the unaudited financial results for the quarter and half year ended 30th June 2019 (Q2).
22-Apr-2019 07-May-2019 Quarterly Results
11-Feb-2019 26-Feb-2019 Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2019 ,inter alia, to consider and approve The audited accounts for the year ended 31st December 2018. Recommend final dividend for the period mentioned above.